Results 51 to 60 of about 6,345 (201)
Protocol for qualitative research: Patients' and prescribers' experiences of Gabapentinoids for pain
, 2023 Patients' and prescribers' experiences of Gabapentinoids for ...
Rachel Routledge
core +1 more source
Perioperative Use of Gabapentinoids: Comment [PDF]
Anesthesiology, 2021 Po-Yi Paul Su, Zhonghui Guan
openaire +6 more sources
Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study
BJGP Open, 2021 Background: In 2013 pregabalin was subsidised by Australia’s Pharmaceutical Benefits Scheme (PBS) for neuropathic pain. Since the subsidy, pregabalin prescribing has been increasing in Australia and so has related harm.
Andrea L Schaffer +4 more
doaj +1 more source
Epilepsia, EarlyView.Abstract Objective Despite elevated risk for epilepsy following traumatic brain injury (TBI), there are limited tools to assess epilepsy risk following TBI using routine clinical data. The objective of this study was to develop and validate a machine learning approach to predict the onset of posttraumatic epilepsy (PTE) over varying time horizons ...
Mustafa Ozmen +6 more
wiley +1 more source
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
Frontiers in Psychiatry, 2021 Introduction: Gabapentinoid drugs (gabapentin and pregabalin) are widely used worldwide for epileptic and pain disorders. First signals of gabapentinoid abuse occurred in the last decade.
Marine Tambon +10 more
doaj +1 more source
Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough
The Laryngoscope, EarlyView.The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen +3 more
wiley +1 more source
Consumption pattern of gabapentinoids in a tertiary health-care system: a five year study from 2012-2017 [PDF]
, 2019 Background: Treating chronic pain has always been a great challenge for the treating physician. As the available pharmacotherapy do not always yield desired results, wider armamentarium is needed in tackling the chronic pain.
A., Tejus, Sinha, Sharmila
core +1 more source
Breaking Mental Barriers Promotes Recovery After Spinal Cord Injury
Frontiers in Molecular Neuroscience, 2022 Functional recovery after spinal cord injury (SCI) often proves difficult as physical and mental barriers bar survivors from enacting their designated rehabilitation programs.
Haven I. Rodocker +12 more
doaj +1 more source
High Prevalence and Clinical Impact of Fibromyalgia in Functional Motor Disorder
Movement Disorders Clinical Practice, EarlyView.Abstract Background Fibromyalgia is characterized by widespread pain, fatigue, sleep and cognitive symptoms. It overlaps clinically with functional motor disorder (FMD), yet its prevalence and impact in FMD remain uncertain. Objective To determine the prevalence of fibromyalgia in FMD using the current criteria and evaluate its effects on motor ...
Tereza Serranová +6 more
wiley +1 more source
Deprescribing interventions for gabapentinoids in adults: A scoping review
British Journal of Clinical Pharmacology, 2022 AbstractThe emerging issue of rising gabapentinoid misuse is being recognized alongside the lack of current evidence supporting the safe and effective deprescribing of gabapentinoids. This scoping review aimed to assess the extent and nature of gabapentinoid deprescribing interventions in adults, either in reducing dosages, or prescribing of ...
Prue A. Anderson +5 more
openaire +3 more sources